These findings are consistent with our previous studies, which demonstrated a barrier-protective effect of the artificial sweetener, sucralose, in settings of VEGF-induced retinopathy and LPS-induced pulmonary edema [7,8]. Here, VEGFA is linked to retinal disorder.